Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Onxeo Plunges After Liver Cancer Drug Fails Late-Stage Study

Shares of Onxeo were down more than 50 percent after the company’s Phase III liver cancer drug Livatag failed to improve survivability over standard of care.

Read More »

Alexion Wants Fresh Start, Slashes 20% of Jobs and Will Move HQ to Boston

Alexion Pharmaceuticals announced plans to cut costs by closing several sites, moving its headquarters and laying off 20 percent of staff. The job cuts follow 210 layoffs in March 2017.

Read More »

Novartis says biosimilar rituximab accepted for review by FDA

Novartis AG’s biosimilar rituximab to treat blood cancers and immunological diseases such as rheumatoid arthritis was accepted for review by the U.S. FDA.

Read More »

U.S. tribal patent deal could have big impact on generic drug market

A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company’s patents in administrative proceedings could also be used be to protect them from challenges in federal court, legal experts said, potentially dealing a blow to generic competition.

Read More »

New Shire drug significantly reduces HAE attacks

London-listed drugmaker Shire successfully tested a new medicine that prevents attacks in patients with hereditary angioedema (HAE).

Read More »

Two Deaths Hit AbbVie’s Late-Stage RA Study

AbbVie announced positive top-line results from its Phase III clinical trial of upadacitinib (ABT-494) in moderate-to-severe rheumatoid arthritis patients.

Read More »

Driving Global Clinical Trial Success: Four Top Strategies

The pharma landscape has significantly evolved in the last decade, especially when it comes to clinical trials.

Read More »

J&J Ends Hep C Drug Program

Janssen Sciences Ireland UC, a Johnson & Johnson company, announced the decision to halt development of its hepatitis C treatment combination JNJ-4178.

Read More »

Cancer immunotherapy proves itself in earlier-stage disease

Cancer doctors are widening the net for immunotherapy, a hot new class of drugs that enlist the body’s defenses in the fight against tumors.

Read More »

Teva Pharmaceutical Hires New CEO

After six months, Teva Pharmaceutical’s search ended as the company hired a new chief executive officer.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom